Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AYTU BIOPHARMA, INCFinancial_Report.xls
10-Q - QUARTERLY REPORT - AYTU BIOPHARMA, INCrosewind10q22912_462012.htm
EX-31.1 - EXHIBIT 31.1 - AYTU BIOPHARMA, INCrosewind10q22912x31_462012.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


The undersigned, James B. Wiegand, Chief Executive Officer of Rosewind Corporation (the “Company”), certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Quarterly Report on Form 10-Q of the Company for the quarter ended February 29, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ James B. Wiegand
James B. Wiegand
Principal Executive Officer and Principal Financial Officer
April 12, 2012